The 1 analysts offering 12-month price forecasts for Vascular Biogenics Ltd have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +2,264.07% increase from the last price of 0.21.
The current consensus among 1 polled investment analysts is to Hold stock in Vascular Biogenics Ltd. This rating has held steady since November, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.14
Reporting Date Mar 14
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.